Johnson & Johnson (JNJ) Share-based Compensation (2009 - 2026)

Johnson & Johnson has disclosed Share-based Compensation across 18 years of filings, most recently posting $300.0 million for Q1 2026.

• Share-based Compensation for Q1 2026 came in at $300.0 million, up 4.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 billion (up 17.56% YoY), and the FY2025 annual result was $1.4 billion, up 15.14% from the prior year.
• Share-based Compensation came in at $300.0 million for Q1 2026 at Johnson & Johnson, down from $309.0 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $410.0 million in Q2 2025 to a low of $178.0 million in Q4 2023.
• The 5-year median for Share-based Compensation is $300.0 million (2026), against an average of $299.2 million.
• Across the five-year window, Share-based Compensation slipped 18.35% in 2023 and surged 33.71% in 2024, its largest moves.
• Johnson & Johnson's Share-based Compensation stood at $278.0 million in 2022, then slumped by 35.97% to $178.0 million in 2023, then jumped by 33.71% to $238.0 million in 2024, then increased by 29.83% to $309.0 million in 2025, then slipped by 2.91% to $300.0 million in 2026.
• The last three Share-based Compensation figures came in at $300.0 million (Q1 2026), $309.0 million (Q4 2025), and $347.0 million (Q3 2025), per Business Quant data.